Published in Phys Med Biol on October 21, 2004
Estimation of α/β for late rectal toxicity based on RTOG 94-06. Int J Radiat Oncol Biol Phys (2011) 2.96
The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int J Radiat Oncol Biol Phys (2014) 2.28
Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data. Int J Radiat Oncol Biol Phys (2012) 2.12
Radiation-induced effects and the immune system in cancer. Front Oncol (2012) 1.27
Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol (2008) 1.21
Hypofractionation for prostate cancer. Cancer J (2009) 1.21
Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys (2011) 1.16
Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia. Int J Radiat Oncol Biol Phys (2010) 1.13
Cyberknife: A double edged sword? Rep Pract Oncol Radiother (2010) 1.10
Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation. J Radiat Res (2012) 1.06
The confluence of stereotactic ablative radiotherapy and tumor immunology. Clin Dev Immunol (2011) 1.05
Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer. Semin Radiat Oncol (2008) 1.04
Radiotherapy and the tumor stroma: the importance of dose and fractionation. Front Oncol (2014) 0.95
Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses. J Radiat Res (2012) 0.95
What would be the most appropriate α/β ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer. Biomed Res Int (2013) 0.91
Review of stereotactic radiosurgery for intramedullary spinal lesions. Korean J Spine (2013) 0.89
Optimal solution for a cancer radiotherapy problem. J Math Biol (2013) 0.86
Stereotactic body radiotherapy treatment of extracranial metastases. Nat Rev Clin Oncol (2012) 0.84
In silico analysis of cell cycle synchronisation effects in radiotherapy of tumour spheroids. PLoS Comput Biol (2013) 0.84
The modified linear-quadratic model of Guerrero and Li can be derived from a mechanistic basis and exhibits linear-quadratic-linear behaviour. Phys Med Biol (2005) 0.84
Radiobiology of radiosurgery for the central nervous system. Biomed Res Int (2013) 0.83
Re-irradiation: outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic region. Technol Cancer Res Treat (2012) 0.81
The biology of radiosurgery and its clinical applications for brain tumors. Neuro Oncol (2014) 0.81
Big Data Analytics for Prostate Radiotherapy. Front Oncol (2016) 0.80
Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules? J Radiat Res (2016) 0.80
Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects. Radiat Oncol (2017) 0.79
Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy. Radiat Res (2014) 0.78
A systems biology approach to radiation therapy optimization. Radiat Environ Biophys (2010) 0.78
The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions. Front Oncol (2016) 0.76
Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes. J Clin Oncol (2014) 0.76
Isoeffect calculations with the linear quadratic and its extensions: An examination of model-dependent estimates at doses relevant to hypofractionation. J Med Phys (2011) 0.76
Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data? Radiat Oncol (2016) 0.75
Using state variables to model the response of tumour cells to radiation and heat: a novel multi-hit-repair approach. Comput Math Methods Med (2013) 0.75
Radiosensitivity and relative biological effectiveness based on a generalized target model. J Radiat Res (2016) 0.75
The radiosurgery fractionation quandary: single fraction or hypofractionation? Neuro Oncol (2017) 0.75
Therapeutic analysis of high-dose-rate (192)Ir vaginal cuff brachytherapy for endometrial cancer using a cylindrical target volume model and varied cancer cell distributions. Med Phys (2016) 0.75
Modeling Radiotherapy Induced Normal Tissue Complications: An Overview beyond Phenomenological Models. Comput Math Methods Med (2016) 0.75
Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. Radiother Oncol (2016) 0.75
Optimal weekly scheduling in fractionated radiotherapy: effect of an upper bound on the dose fraction size. J Math Biol (2014) 0.75
Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys (2010) 2.94
Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys (2010) 2.69
How low is the alpha/beta ratio for prostate cancer? Int J Radiat Oncol Biol Phys (2003) 2.46
Radiation-associated liver injury. Int J Radiat Oncol Biol Phys (2010) 2.39
Accelerator beam data commissioning equipment and procedures: report of the TG-106 of the Therapy Physics Committee of the AAPM. Med Phys (2008) 1.89
Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys (2010) 1.74
Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer. Phys Med Biol (2004) 1.63
Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys (2003) 1.45
Tools for consensus analysis of experts' contours for radiotherapy structure definitions. Radiother Oncol (2010) 1.36
Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.32
Renin-Angiotensin system suppression mitigates experimental radiation pneumonitis. Int J Radiat Oncol Biol Phys (2009) 1.25
Evaluation of a commercial biologically based IMRT treatment planning system. Med Phys (2008) 1.22
Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study. Int J Radiat Oncol Biol Phys (2004) 1.19
Direct aperture optimization-based intensity-modulated radiotherapy for whole breast irradiation. Int J Radiat Oncol Biol Phys (2007) 1.14
Clinical implementation of intensity-modulated arc therapy. Int J Radiat Oncol Biol Phys (2002) 1.10
Respiratory organ motion and dosimetric impact on breast and nodal irradiation. Int J Radiat Oncol Biol Phys (2010) 1.08
Role of the angiotensin II type-2 receptor in radiation nephropathy. Transl Res (2007) 1.07
Is α/β for breast cancer really low? Radiother Oncol (2011) 1.03
Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.00
An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications. Cancers (Basel) (2012) 1.00
Cardiac injury after 10 gy total body irradiation: indirect role of effects on abdominal organs. Radiat Res (2013) 0.99
Intra- and interfractional variations for prone breast irradiation: an indication for image-guided radiotherapy. Int J Radiat Oncol Biol Phys (2007) 0.98
Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma. Med Phys (2004) 0.98
Dosimetric impact of intrafraction motion for compensator-based proton therapy of lung cancer. Phys Med Biol (2008) 0.98
The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us? Int J Radiat Oncol Biol Phys (2003) 0.97
Irradiation of varying volumes of rat lung to same mean lung dose: a little to a lot or a lot to a little? Int J Radiat Oncol Biol Phys (2008) 0.97
Improved critical structure sparing with biologically based IMRT optimization. Med Phys (2009) 0.97
An on-line replanning method for head and neck adaptive radiotherapy. Med Phys (2009) 0.95
Automated registration of large deformations for adaptive radiation therapy of prostate cancer. Med Phys (2009) 0.94
An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor. Int J Radiat Oncol Biol Phys (2006) 0.94
An on-line replanning scheme for interfractional variations. Med Phys (2008) 0.92
Report of AAPM Therapy Physics Committee Task Group 74: in-air output ratio, Sc, for megavoltage photon beams. Med Phys (2009) 0.92
Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. Med Phys (2003) 0.92
Characterization and management of interfractional anatomic changes for pancreatic cancer radiotherapy. Int J Radiat Oncol Biol Phys (2012) 0.92
Equivalence of the linear-quadratic and two-lesion kinetic models. Phys Med Biol (2002) 0.92
In vivo verification of superficial dose for head and neck treatments using intensity-modulated techniques. Med Phys (2009) 0.91
Investigation of helical tomotherapy for partial-breast irradiation of prone-positioned patients. Int J Radiat Oncol Biol Phys (2009) 0.91
Estimate of radiobiologic parameters from clinical data for biologically based treatment planning for liver irradiation. Int J Radiat Oncol Biol Phys (2008) 0.91
Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys (2005) 0.89
Gated treatment delivery verification with on-line megavoltage fluoroscopy. Int J Radiat Oncol Biol Phys (2010) 0.89
BGRT: biologically guided radiation therapy-the future is fast approaching! Med Phys (2007) 0.88
Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models. Radiother Oncol (2007) 0.88
Impact of tumor repopulation on radiotherapy planning. Int J Radiat Oncol Biol Phys (2005) 0.88
Online adaptive replanning method for prostate radiotherapy. Int J Radiat Oncol Biol Phys (2010) 0.87
Halftime for repair of sublethal damage in normal bladder and rectum: an analysis of clinical data from cervix brachytherapy. Phys Med Biol (2006) 0.85
Impact of computed tomography image quality on image-guided radiation therapy based on soft tissue registration. Int J Radiat Oncol Biol Phys (2012) 0.84
Multi-system verification of registrations for image-guided radiotherapy in clinical trials. Int J Radiat Oncol Biol Phys (2011) 0.84
Dynamic MRI analysis of tumor and organ motion during rest and deglutition and margin assessment for radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys (2011) 0.84
Implementation of remote 3-dimensional image guided radiation therapy quality assurance for radiation therapy oncology group clinical trials. Int J Radiat Oncol Biol Phys (2012) 0.83
Dose perturbations due to contrast medium and air in mammosite treatment: an experimental and Monte Carlo study. Med Phys (2005) 0.82
Validation of an online replanning technique for prostate adaptive radiotherapy. Phys Med Biol (2011) 0.82
Extrapolation of normal tissue complication probability for different fractionations in liver irradiation. Int J Radiat Oncol Biol Phys (2009) 0.81
Interfractional target variations for partial breast irradiation. Int J Radiat Oncol Biol Phys (2011) 0.81
Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning. Phys Med Biol (2003) 0.81
Assessment of interfraction patient setup for head-and-neck cancer intensity modulated radiation therapy using multiple computed tomography-based image guidance. Int J Radiat Oncol Biol Phys (2013) 0.80
Accumulating daily-varied dose distributions of prostate radiation therapy with soft-tissue-based kV CT guidance. J Appl Clin Med Phys (2012) 0.80
Respiration induced heart motion and indications of gated delivery for left-sided breast irradiation. Int J Radiat Oncol Biol Phys (2011) 0.80
Development of an inverse optimization package to plan nonuniform dose distributions based on spatially inhomogeneous radiosensitivity extracted from biological images. Med Phys (2007) 0.80
Investigation of the reliability, accuracy, and efficiency of gated IMRT delivery with a commercial linear accelerator. Med Phys (2007) 0.80
Monte Carlo dose calculations in homogeneous media and at interfaces: a comparison between GEPTS, EGSnrc, MCNP, and measurements. Med Phys (2002) 0.79
Automated computer optimization for 3D treatment planning of breast irradiation. Med Phys (2008) 0.79
A comparison of daily megavoltage CT and ultrasound image guided radiation therapy for prostate cancer. Med Phys (2008) 0.79
Comparison of various online strategies to account for interfractional variations for pancreatic cancer. Int J Radiat Oncol Biol Phys (2013) 0.78
Internal margin assessment using cine MRI analysis of deglutition in head and neck cancer radiotherapy. Med Phys (2011) 0.78
Dosimetric comparison of two 90Sr/90Y sources for intravascular brachytherapy: an EGSnrc Monte Carlo calculation. Phys Med Biol (2002) 0.78
Management of respiration-induced motion with 4-dimensional computed tomography (4DCT) for pancreas irradiation. Int J Radiat Oncol Biol Phys (2013) 0.78
Dose characterization in the near-source region for two high dose rate brachytherapy sources. Med Phys (2002) 0.77
An analysis of tumor control probability of stereotactic body radiation therapy for lung cancer with a regrowth model. Phys Med Biol (2016) 0.76
A technique to sharpen the beam penumbra for Gamma Knife radiosurgery. Phys Med Biol (2003) 0.76
Possible fractionated regimens for image-guided intensity-modulated radiation therapy of large arteriovenous malformations. Phys Med Biol (2007) 0.76
Using a photon phase-space source for convolution/superposition dose calculations in radiation therapy. Phys Med Biol (2005) 0.76
MRI-based IMRT planning for MR-linac: comparison between CT- and MRI-based plans for pancreatic and prostate cancers. Phys Med Biol (2016) 0.76
A Comment on Qi et al. An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications-Authors' Reply. Cancers (Basel) (2012) 0.75
Modeling prostate cancer: in regards to Nahum et al. (Int J Radiat Oncol Biol Phys 2003;57:391-401). Int J Radiat Oncol Biol Phys (2005) 0.75
Dose effect of guidewire position in intravascular brachytherapy. Phys Med Biol (2002) 0.75
Monte Carlo dose characterization of a new 90Sr/90Y source with balloon for intravascular brachytherapy. Med Phys (2003) 0.75
IVBTMC, a Monte Carlo dose calculation tool for intravascular brachytherapy. Med Phys (2003) 0.75
Patient-specific margins for proton therapy of lung. Australas Phys Eng Sci Med (2007) 0.75
Clinical experience with planning, quality assurance, and delivery of burst-mode modulated arc therapy. J Appl Clin Med Phys (2016) 0.75
Comparing the quality of passively-scattered proton and photon tomotherapy plans for brain and head and neck disease sites. Phys Med Biol (2015) 0.75
The management of patients with esophageal cancer and coronary artery stenosis undergoing radiotherapy or concurrent chemoradiotherapy: a single-center experience. J BUON (2016) 0.75
A Monte-Carlo derived dual-source model for helical tomotherapy treatment planning. Technol Cancer Res Treat (2008) 0.75
Dosimetric effects of source-offset in intravascular brachytherapy. Med Phys (2002) 0.75